Brookdale Senior Living (BKD) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- -$0.02
- Estimate
- -$0.04
- Surprise
- +47.0%
- Revenue (period 2026-06-30)
- $718.6M
- Score today
- 5.1/10
Revenue source: xbrl.
How the report landed
Brookdale Senior Living (BKD) reported a narrower loss than forecast — diluted EPS of -$0.02 against the -$0.04 estimate (a 47.0% beat on a still-unprofitable quarter).
Where TrendMatrix's rating stands now
TrendMatrix currently rates BKD Sell at 5.1/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +47.0% surprise compares with a +33.7% four-quarter average. Next scheduled report: 2026-11-05.
What argues against it
- Concentration risk — Customer: private pay residents (93.9%)
- Quality below floor (2.5 < 4.0)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $11.83
- Price target
- $16.75
- Stop
- $11.24
- Upside to target
- +41.6%
- Reward-to-risk
- 6.6:1
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
BKD at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $2.85B
- P/E (fwd)
- 70.2
- 52-week range
- $7.29–$17.09
- Off 52-week high
- 30.8%
- RSI (14)
- 38
- Volume vs avg
- 0.35×
- Score today
- 5.1/10